# |
18/01/2022* |
Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG)) |
 |
# |
14/01/2022* |
Clinical Guidance for Management of Adult COVID-19 Patients |
|
# |
08/11/2021* |
Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG)) |
 |
# |
02/08/2021* |
Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG)) |
 |
# |
28/06/2021* |
Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG)) |
 |
# |
06/08/2020 |
Invitation for submitting Letter of Intent for Participation in National Clinical Registry of COVID-19 |
|
# |
30/07/2020 |
Agenda of International Symposium on Novel Ideas in Science and Ethics of Vaccines against COVID-19 pandemic on July 30, 2020 |
 |
# |
23/07/2020 |
Establishing of a network of Biorepositories in India |
|
# |
23/05/2020 |
Establishing of a network of Biorepositories in India |
|
# |
22/05/2020 |
Establishing of a network of Biorepositories in India |
|
# |
22/05/2020 |
List of approved institutions for PLACID Trial |
 |
# |
15/05/2020 |
List of approved institutions for PLACID Trial |
 |
# |
11/05/2020 |
List of approved institutions for PLACID Trial |
 |
# |
10/05/2020 |
List of approved institutions for PLACID Trial |
 |
# |
08/05/2020 |
List of approved institutions for PLACID Trial |
 |
# |
04/05/2020 |
List of approved institutions for PLACID Trial |
 |
# |
21/04/2020* |
Call for proposals under the TF on Translational Immunology |
 |
# |
12/04/2020 |
Call for Letter of Intent for Participation in: Therapeutic Plasma Exchange in COVID-19: Protocol for a Multi-center, Phase II, Open Label, Randomized Controlled Study |
|
# |
12/04/2020 |
Call for Letter of Intent for Participation in: A Phase II, Open Label, Randomized Controlled Study to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications |
|
# |
03/04/2020 |
Therapeutic trial for COVID-19 |
|